Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Vera Therapeutics, Inc. (VERA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 42,345,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Vera Therapeutics is a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Co.'s primary product candidate, atacicept, a self-administered fusion protein that blocks both blisibimod and APRIL, is being evaluated for the treatment of immunoglobulin A nephropathy in a global, randomized, double-blind, placebo-controlled clinical trial. Co. has obtained worldwide, exclusive development and commercial rights from Amplyx Pharmaceuticals, Inc., a wholly owned subsidiary of Pfizer Inc., for MAU868, a potentially monoclonal antibody to treat BK viremia infections.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 161,290 614,507 4,957,633
Total Buy Value $0 $4,999,990 $11,881,994 $42,392,668
Total People Bought 0 1 3 8
Total Buy Transactions 0 1 3 27
Total Shares Sold 958,650 2,008,650 2,016,840 2,287,944
Total Sell Value $39,017,864 $57,917,864 $58,054,276 $63,362,460
Total People Sold 3 4 7 8
Total Sell Transactions 6 7 10 41
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 110
  Page 5 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Curley Joanne Chief Development Officer   •       –      –    2022-07-14 4 OE $2.90 $18,406 D/D 6,354 27,377     -
   Curley Joanne Chief Development Officer   •       –      –    2022-07-07 4 AS $15.03 $145,453 D/D (9,666) 21,023     -
   Curley Joanne Chief Development Officer   •       –      –    2022-07-07 4 OE $2.90 $32,401 D/D 7,001 27,202     -
   Curley Joanne Chief Development Officer   •       –      –    2022-06-22 4 AS $15.01 $23,198 D/D (1,545) 23,688     -
   Curley Joanne Chief Development Officer   •       –      –    2022-06-22 4 OE $6.37 $7,896 D/D 1,239 25,233     -
   Curley Joanne Chief Development Officer   •       –      –    2022-06-17 4 AS $15.03 $88,565 D/D (5,887) 23,994     -
   Curley Joanne Chief Development Officer   •       –      –    2022-06-17 4 OE $2.90 $18,256 D/D 4,687 28,535     -
   Grant Sean Chief Financial Officer   •       –      –    2022-06-15 4 B $13.60 $68,004 I/I 5,000 992 1.99     -
   Curley Joanne Chief Development Officer   •       –      –    2022-05-31 4 AS $15.22 $6,086 D/D (400) 25,194     -
   Curley Joanne Chief Development Officer   •       –      –    2022-05-31 4 OE $6.37 $2,549 D/D 400 25,594     -

  110 Records found
  1  2  3  4  5    
  Page 5 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed